Literature DB >> 2858509

A platelet-derived immunoregulatory serum factor with T cell affinity.

I R Katz, M K Hoffmann, M B Zucker, M K Bell, G J Thorbecke.   

Abstract

A factor in mouse and human serum which enhances immune responses to SRBC and TNP-Ficoll in mice has been described. This factor completely reverses immunosuppression induced by syngeneic lymphoma (RCS) or allogeneic lymph node cells. T lymphocytes bind this factor, since the activity can be removed from serum by absorption with T cell containing spleen cells or cloned cytotoxic T lymphocytes. Furthermore, the factor is active only in the presence of mature T cells. Platelet alpha-granules seem to be the source of this serum factor because 1) the activity is lacking in plasma, in serum prepared in the absence of platelets, and in serum prepared from a patient lacking platelet alpha-granules and 2) isolated mouse or human platelets release an immunostimulatory factor with very similar properties upon incubation with thrombin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858509

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 2.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

3.  Immunoregulatory activity of peptides related to platelet factor 4.

Authors:  M B Zucker; I R Katz; G J Thorbecke; D C Milot; J Holt
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Effects of injection routes of growing tumors and PSK or OK-432 on antiproliferative activity of mouse serum.

Authors:  C Ryoyama; K Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Protease-induced immunoregulatory activity of platelet factor 4.

Authors:  I R Katz; G J Thorbecke; M K Bell; J Z Yin; D Clarke; M B Zucker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

6.  Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.

Authors:  A M Gewirtz; B Calabretta; B Rucinski; S Niewiarowski; W Y Xu
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

7.  Inflammation-Related Markers and Thyroid Function Measures in Pediatric Patients: Is the Grade of Obesity Relevant?

Authors:  Ioana Țaranu; Cecilia Lazea; Victoria Creț; Nicoleta Răcătăianu; Mihaela Iancu; Sorana D Bolboacă
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.